Through literature research, we found that MYO1B is associated with the development of various malignancies and enhances tumor cell migration and invasion in colorectal cancer by activating the RhoA/ROCK/FAK signaling pathway (Chen et al., 2022). Here, MYO1B is linked to colorectal cancer.